FDA expands Pluvicto indication to adults with PSMA+ metastatic castration-resistant prostate cancer previously treated with ...
Hosted on MSN14d
Common and lesser known symptoms of kidney cancerKidney Cancer is an abnormal growth in the kidney ... blood and urine examination and PET scan are important to identify and for the staging of the tumor. Usually, kidney tumors are treated ...
27don MSN
Multiple myeloma is a relatively rare blood cancer that ... Bone damage and kidney damage are frequently seen in patients with multiple myeloma. So X-rays, MRIs and PET scans are frequently ...
March is Kidney Cancer Awareness Month, highlighting the disease, early detection and and patient advocacy, with voices like ...
Get Instant Summarized Text (Gist) A urine test analyzing glycosaminoglycans (GAGome) can detect kidney cancer recurrence with high sensitivity, potentially reducing the need for frequent CT scans ...
A simple urine test could accurately show the recurrence of kidney cancer at an early stage, potentially sparing patients invasive scans and enabling faster access to treatment, new research has ...
5d
News-Medical.Net on MSNSimple urine test may spare kidney cancer patients from invasive scansA simple urine test could accurately show the recurrence of kidney cancer at an early stage, potentially sparing patients invasive scans and enabling faster access to treatment, new research has shown ...
More than one-third of patients with PSA levels less than 0.5 ng/mL after primary radical prostatectomy for prostate cancer have PSMA ... emission tomography (PET) scans from 415 patients with ...
The fancy full-body scan that has become the new medical trend ... revealed in January that he had surgery in 2023 to remove kidney cancer. Wade previously said the discovery came after health ...
A simple urine test could accurately show the recurrence of kidney cancer at an early stage, potentially sparing patients invasive scans and enabling faster access to treatment, new research has ...
The company presented its results this week at a conference and anticipates that with additional validation early next year, it will be ready to file for regulatory approval.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results